Compare

AbbVie vs Eli Lilly

AbbVie (ABBV) and Eli Lilly (LLY) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

AbbVie ABBVNYSE · PharmaceuticalsEli Lilly LLYNYSE · Pharmaceuticals
Insider records, last 12 months88378
Congress trades, last 12 months1224
Fund positions reported, last 12 months483709
Federal contract awards, last 12 months82
Open-market purchases by insiders since 20062535
Open-market sales by insiders since 20065376,838
Last open-market purchase by an insiderMar 30, 2020Aug 15, 2025
Next resultsOct 30, 2026Oct 29, 2026

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, AbbVie or Eli Lilly?

Since 2006, Eli Lilly insiders reported 35 open-market purchases against 25 for AbbVie, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.

Do members of Congress trade ABBV or LLY?

In the last 12 months, members of Congress disclosed 12 trades in AbbVie (ABBV) and 24 in Eli Lilly (LLY), each reported as a value range on a periodic transaction report.

When did insiders last buy ABBV and LLY?

AbbVie: Mar 30, 2020. Eli Lilly: Aug 15, 2025. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen AbbVie free$9.99 a month, cancel anytime

AbbVie pageEli Lilly pageRare insider trades this weekAll comparisons

https://oqro.io/compare/abbv-vs-lly